Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug 24;20(1):348.
doi: 10.1186/s12936-021-03883-z.

The impact of malaria during pregnancy on low birth weight in East-Africa: a topical review

Affiliations
Review

The impact of malaria during pregnancy on low birth weight in East-Africa: a topical review

Line Bakken et al. Malar J. .

Abstract

Background: Globally, approximately 15% of all babies are born with low birth weight (< 2.5 kg) and ≥ 90% of them are born in low- and middle-income countries. Malaria infection in pregnancy remains a public health concern as it can affect both the mother and the newborn. Notably, it increases the risk of newborns with low birth weight. The World Health Organization (WHO) recommends intermittent preventive treatment with ≥ 3 doses of sulfadoxine-pyrimethamine (SP) during pregnancy in areas with moderate to high malaria transmission in Africa. The aim of this topical review is to give an overview of the impact of malaria infection during pregnancy on low birth weight, with focus on East Africa where malaria is endemic.

Methods: Eleven studies were selected according to a predefined set of criteria.

Results: Three studies showed a significant reduction in the prevalence of low birth weight with intermittent preventive treatment with SP, whereas four studies found no significant impact of such treatment on low birth weight. The number of SP doses and compliance to this treatment may in part explain these discrepancies. Pregnant women with frequent symptomatic malaria infection had significantly higher risk of placental malaria.

Conclusion: The WHO recommendation of ≥ 3 doses of intermittent preventive treatment with SP during pregnancy seem effective in preventing low birth weight, but treatment compliance is a challenge. Malaria prophylaxis is important during pregnancy, especially in endemic areas of malaria, such as East Africa.

Keywords: East Africa; Low birth weight; Malaria; Pregnancy; Sulfadoxine-pyrimethamine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Flow chart showing the selection of articles included in this topical review

References

    1. WHO. World malaria report 2020. Geneva: World Health Organization; 2020. https://www.who.int/publications/i/item/9789240015791. Accessed 29 May 2021.
    1. McClure EM, Goldenberg RL, Dent AE, Meshnick SR. A systematic review of the impact of malaria prevention in pregnancy on low birth weight and maternal anemia. Int J Gynaecol Obstet. 2013;121:103–109. doi: 10.1016/j.ijgo.2012.12.014. - DOI - PubMed
    1. WHO. Reducing the burden of malaria in pregnancy. Geneva: World Health Organization, 2003. https://www.who.int/malaria/publications/atoz/merajan2003.pdf. Accessed 29 May 2021.
    1. Kapisi J, Kakuru A, Jagannathan P, Muhindo MK, Natureeba P, Awori P, et al. Relationships between infection with Plasmodium falciparum during pregnancy, measures of placental malaria, and adverse birth outcomes. Malar J. 2017;16:400. doi: 10.1186/s12936-017-2040-4. - DOI - PMC - PubMed
    1. Blencowe H, Krasevec J, de Onis M, Black RE, An X, Stevens GA, et al. National, regional, and worldwide estimates of low birthweight in 2015, with trends from 2000: a systematic analysis. Lancet Glob Health. 2019;7:e849–e860. doi: 10.1016/S2214-109X(18)30565-5. - DOI - PMC - PubMed